ANVISA
- Status: likely_approved
🇧🇷 Saphnelo in Brazil
Saphnelo (ANIFROLUMAB) regulatory status in Brazil.
Marketing authorisation
Saphnelo in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in Brazil
Frequently asked questions
Is Saphnelo approved in Brazil?
Yes. ANVISA has authorised it.
Who is the marketing authorisation holder for Saphnelo in Brazil?
AstraZeneca is the originator. The local marketing authorisation holder may differ — check the official source linked above.